MGX News
Archived Headlines
- US IPO Week Ahead: Real estate, groceries, insurance, and more come to the IPO market 02/02/24
- Large filers bolster strong outlook for the 2024 IPO market 01/11/24
- US IPO Weekly Recap: 2024 IPO market starts off with two billion-dollar additions to the pipeline 01/05/24
- Gene editing biotech Metagenomi files for a $100 million IPO 01/05/24
Renaissance Capital's February IPO Market Update
In February, 10 IPOs raised a combined $2.0 billion, led by early debuts from a handful of $100+ million offerings. Deal flow was led by healthcare and senior facilities provider American Healthcare REIT (AHR) and Mexican discount grocer BBB Foods (TBBB),...read more
US IPO Weekly Recap: Autoimmune biotech Kyverna Therapeutics gains 37% in a 6 IPO week
Six IPOs priced this past week, joined by two blank check companies.One larger deal did not get done: Fortegra (TFG) pulled its $297 million offering ahead of its expected pricing. The specialty insurer had previously attempted to go public in early 2021 but...read more
Gene editing biotech Metagenomi prices IPO at $15, the low end of the range
Metagenomi, a preclinical biotech using metagenomics-derived genome editing, raised $94 million by offering 6.3 million shares at $15, the low end of the range of $15 to $17. Metagenomi is a precision genetic medicines company developing curative therapeutics...read more
Gene editing biotech Metagenomi sets terms for $100 million IPO
Metagenomi, a preclinical biotech developing therapies using metagenomics-derived genome editing, announced terms for its IPO on Monday.The Emeryville, CA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more